A novel gene therapy has been developed to convert glioma cells into functional neurons, offering a new approach to treating the disease. This technology may prolong treatment time by arresting rapid proliferation of malignant glioma cells.
A research team led by Prof. Gong Chen has developed a novel gene therapy approach to regenerate functional new neurons using local glial cells in the injured spinal cord. This method uses internal glial cells and directly converts them into neurons, offering a promising therapeutic intervention for patients with spinal cord injury.
Researchers have developed a novel neuroregenerative gene therapy that converts glial cells back into functional neurons, reversing glial scar tissue. This treatment also promotes brain recovery in mouse models of ischemic stroke and Huntington's disease, offering a promising solution to the glial scar problem.
A study published on Frontiers in Cell and Developmental Biology found successful neural regeneration from brain internal glial cells for stroke repair in rhesus macaque monkeys. This gene therapy approach regenerates new neurons while also protecting injured neurons from secondary damage.
Researchers at Jinan University successfully convert astrocytes into neurons using transgenic reporter mice and AAV viral system, providing unambiguous evidence of direct glia-to-neuron conversion. The findings dispel controversies in the field and offer a promising technology for treating neurological disorders.
A novel gene therapy has been developed to regenerate functional new neurons in mouse models of Huntington's Disease, offering a potential treatment for the condition. The therapy uses NeuroD1-based gene therapies to convert brain internal glial cells into functional new neurons.
Exercise induces improved motor skills through activation of the mechanistic target of rapamycin (mTOR) pathway, which stimulates spinogenesis and neural plasticity. The study provides direct evidence that exercise-activated mTOR is necessary for enhanced cognitive functions.